ILDSTAD SUZANNE (Chief Scientific Officer) sold 0.2% of their position (6.81K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $14.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/7/2023ACC: 0001209191-23-016811
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-6.81K
Net shares
Net seller
$14.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.81K
Price / share
$2.06
Trade value
$13.99K
% of position
0.2%
3/3/2023
3.07M→3.06M
Total
Net shares
−6.81K
Net value
-$13.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2023 | S · Sale | −6.81K | $2.06 | $13.99K | 0.2% | 3.07M | 3.06M |
| Total | −6.81K | -$13.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned654.21K
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported